Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
07
2026

Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco

BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that management will be meeting…

January
07
2026

Sensus Healthcare Appoints Larry Biscotti to its Board of Directors

BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Larry Biscotti…

December
19
2025

Understanding CMS Codes: How They Impact Your Reimbursement and Patient Care

For many healthcare providers, navigating CMS codes (Centers for Medicare & Medicaid Services codes) can feel like learning another language. Yet these codes are the foundation of proper billing, clean claims, accurate reimbursement, and patient…

November
14
2025

Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer

New responsibilities recognize Mr. Sardano’s significant accomplishments in securing CPT® codes for office-based SRT and the growing commercial opportunity the Company now faces BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy